These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 28142164

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. INTRAVITREAL VERSUS SUBRETINAL ADMINISTRATION OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR COMBINED WITH GAS FOR ACUTE SUBMACULAR HEMORRHAGES DUE TO AGE-RELATED MACULAR DEGENERATION: An Exploratory Prospective Study.
    de Jong JH, van Zeeburg EJ, Cereda MG, van Velthoven ME, Faridpooya K, Vermeer KA, van Meurs JC.
    Retina; 2016 May; 36(5):914-25. PubMed ID: 26807631
    [Abstract] [Full Text] [Related]

  • 6. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

  • 7. Long-term outcome of subretinal coapplication of rtPA and bevacizumab followed by repeated intravitreal anti-VEGF injections for neovascular AMD with submacular haemorrhage.
    Treumer F, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2012 May; 96(5):708-13. PubMed ID: 22174095
    [Abstract] [Full Text] [Related]

  • 8. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 9. Hemorrhagic age-related macular degeneration managed with vitrectomy, subretinal injection of tissue plasminogen activator, gas tamponade, and upright positioning.
    Kapran Z, Ozkaya A, Uyar OM.
    Ophthalmic Surg Lasers Imaging Retina; 2013 Jun; 44(5):471-6. PubMed ID: 24044710
    [Abstract] [Full Text] [Related]

  • 10. Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.
    Doi S, Kimura S, Morizane Y, Shiode Y, Hosokawa M, Hirano M, Hosogi M, Fujiwara A, Miyamoto K, Shiraga F.
    BMC Ophthalmol; 2015 Aug 07; 15():94. PubMed ID: 26250101
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E, Peroglio Deiro A, Mete M, Sartore M, Polito A, Prigione G, Guerriero M, Pertile G.
    Ophthalmologica; 2020 Aug 07; 243(3):224-235. PubMed ID: 31905361
    [Abstract] [Full Text] [Related]

  • 12. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F.
    Indian J Ophthalmol; 2017 Jun 07; 65(6):482-487. PubMed ID: 28643713
    [Abstract] [Full Text] [Related]

  • 13. Management of submacular hemorrhage with intravitreal versus subretinal injection of recombinant tissue plasminogen activator.
    Hillenkamp J, Surguch V, Framme C, Gabel VP, Sachs HG.
    Graefes Arch Clin Exp Ophthalmol; 2010 Jan 07; 248(1):5-11. PubMed ID: 19669780
    [Abstract] [Full Text] [Related]

  • 14. Submacular hemorrhage in polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
    Kimura S, Morizane Y, Hosokawa M, Shiode Y, Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara A, Inoue Y, Shiraga F.
    Am J Ophthalmol; 2015 Apr 07; 159(4):683-9. PubMed ID: 25555798
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ, Hakim I, Haritoglou C, Gandorfer A, Ulbig M, Kampik A, Wolf A.
    Acta Ophthalmol; 2013 May 07; 91(3):274-8. PubMed ID: 21952010
    [Abstract] [Full Text] [Related]

  • 16. Subretinal injection of recombinant tissue plasminogen activator for submacular hemorrhage associated with ruptured retinal arterial macroaneurysm.
    Inoue M, Shiraga F, Shirakata Y, Morizane Y, Kimura S, Hirakata A.
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct 07; 253(10):1663-9. PubMed ID: 25418034
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of submacular hematoma by vitrectomy, subretinal injection of rtPA and gaseous tamponade: A single-center retrospective observational study].
    Berthon C, Rousseau E, Chiambaretta F.
    J Fr Ophtalmol; 2020 May 07; 43(5):417-426. PubMed ID: 32192752
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.